CTRI/2020/12/029581尚未招募未知
A study of renal manifestations and its outcome in hospitalised patients with Covid 19 at a tertiary care hospital in Dakshina Kannada ,Karnatak - ROCD
nil0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients diagnosed with covid 19 including children either by RT-PCR or rapid antigen test admitted in our hospital.
排除标准
- •Case files where urinary analysis and kidney function evaluation reports are not present.
研究者
相似试验
已完成
3 期
Renal complications of Amikacin in patients with neonatal sepsisIRCT20201212049686N1Tehran University of Medical Sciences90
招募中
不适用
The analysis of renal complication associated with Rheumatoid ArthritisRheumatoid ArhtritisJPRN-UMIN000032529Toranomon hospital120
已完成
不适用
Influence of renal dysfunction on the outcomes of hepatectomy for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000041749Hiroshima University238
进行中（未招募）
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S
进行中（未招募）
1 期
A study to assess the renal function in young male patients with Fabry disease who have never received any specific treatment for this disease.Fabry diseaseMedDRA version: 15.0Level: PTClassification code 10016016Term: Fabry's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2012-001966-14-ESGenzyme, a Sanofi Company39